233
Views
18
CrossRef citations to date
0
Altmetric
Original Articles

Anticancer potential of docetaxel-loaded cobalt ferrite nanocarrier: an in vitro study on MCF-7 and MDA-MB-231 cell lines

, , , , , & show all
Pages 36-46 | Received 16 May 2020, Accepted 21 Oct 2020, Published online: 30 Nov 2020

References

  • Ansari, S.M., et al., 2016. Size and chemistry controlled cobalt-ferrite nanoparticles and their anti-proliferative effect against the MCF-7 breast cancer cells. ACS biomaterials science & engineering, 2 (12), 2139–2152.
  • Azizi, M., et al., 2017. Cytotoxic effect of albumin coated copper nanoparticle on human breast cancer cells of MDA-MB 231. PLoS One, 12 (11), e0188639.
  • Bray, F., et al., 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 68 (6), 394–424.
  • Dey, C., et al., 2017. Improvement of drug delivery by hyperthermia treatment using magnetic cubic cobalt ferrite nanoparticles. Journal of magnetism and magnetic materials, 427, 168–174.
  • Dey, C., et al., 2018. Improvement of anticancer drug release by cobalt ferrite magnetic nanoparticles through combined pH and temperature responsive technique. Chemphyschem: a European journal of chemical physics and physical chemistry, 19 (21), 2872–2878.
  • Fan, H., et al., 2018. A fibrous morphology silica-CoFe2O4 nanocarrier for anti-cancer drug delivery. Ceramics international, 44 (2), 2345–2350.
  • Gaonkar, R.H., et al., 2017. Garcinol loaded vitamin E TPGS emulsified PLGA nanoparticles: preparation, physicochemical characterization, in vitro and in vivo studies. Scientific reports, 7 (1), 530. https://doi.org/10.1038/s41598-017-00696-6
  • Goodarz Naseri, M., et al., 2010. Simple synthesis and characterization of cobalt ferrite nanoparticles by a thermal treatment method [WWW Document]. Journal of nanomaterials, 2010, 1–8.
  • Gupta, A.K. and Wells, S., 2004. Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE transactions on nanobioscience, 3 (1), 66–73.
  • Jain, T.K., et al., 2005. Iron oxide nanoparticles for sustained delivery of anticancer agents. Molecular pharmaceutics, 2 (3), 194–205.
  • Jauhar, S., et al., 2016. Tuning the properties of cobalt ferrite: a road towards diverse applications. RSC advances, 6 (100), 97694–97719.
  • Kazi, J., et al., 2019. Design of 5-fluorouracil (5-FU) loaded, folate conjugated peptide linked nanoparticles, a potential new drug carrier for selective targeting of tumor cells. MedChemComm, 10 (4), 559–572.
  • Lin, Y.-S. and Haynes, C.L., 2009. Synthesis and characterization of biocompatible and size-tunable multifunctional porous silica nanoparticles. Chemistry of materials, 21 (17), 3979–3986.
  • Ling, Y., et al., 2011. Dual docetaxel/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy. Biomaterials, 32 (29), 7139–7150.
  • Maji, R., et al., 2014. Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy. International journal of nanomedicine, 9, 3107–3118.
  • Malvia, S., et al., 2017. Epidemiology of breast cancer in Indian women. Asia-Pacific journal of clinical oncology, 13 (4), 289–295.
  • Mandal, B., et al., 2020. MnFe2O4 decorated reduced graphene oxide heterostructures: nanophotocatalyst for methylene blue dye degradation. Vacuum, 173, 109150.
  • Mandal, D., et al., 2018. Preferential hepatic uptake of paclitaxel-loaded poly-(d-l-lactide-co-glycolide) nanoparticles – a possibility for hepatic drug targeting: pharmacokinetics and biodistribution. International journal of biological macromolecules, 112, 818–830.
  • Mazario, E., et al., 2013. Magnetic hyperthermia properties of electrosynthesized cobalt ferrite nanoparticles. The journal of physical chemistry c, 117 (21), 11405–11411.
  • Mohapatra, S., et al., 2011. Monodisperse mesoporous cobalt ferrite nanoparticles: synthesis and application in targeted delivery of antitumor drugs. Journal of materials chemistry, 21 (25), 9185–9193.
  • Mohtasebzadeh, A.R., Ye, L., and Crawford, T.M., 2015. Magnetic nanoparticle arrays self-assembled on perpendicular magnetic recording media. International journal of molecular sciences, 16 (8), 19769–19779.
  • Moses, S.I., Edwards, V., and Brantley, E., 2016. Cytotoxicity in MCF-7 and MDA-MB-231 breast cancer cells without harming MCF-10A healthy cells. J. Nanomedicine nanotechnol, 7, 2.
  • Panda, J., et al., 2019. Engineered polymeric iron oxide nanoparticles as potential drug carrier for targeted delivery of docetaxel to breast cancer cells. Journal of magnetism and magnetic materials, 485, 165–173.
  • Patil, R.M., et al., 2014. Non-aqueous to aqueous phase transfer of oleic acid coated iron oxide nanoparticles for hyperthermia application. RSC advances, 4 (9), 4515–4522.
  • Paul, P., et al., 2018. Chitosan-coated nanoparticles enhanced lung pharmacokinetic profile of voriconazole upon pulmonary delivery in mice. Nanomedicine (London, England), 13 (5), 501–520.
  • Pourjavadi, A., Amin, S.S., and Hosseini, S.H., 2018. Delivery of hydrophobic anticancer drugs by hydrophobically modified alginate based magnetic nanocarrier. Industrial & engineering chemistry research, 57 (3), 822–832.
  • Rocha-Santos, T.A.P., 2014. Sensors and biosensors based on magnetic nanoparticles. TrAC trends in analytical chemistry, 62, 28–36.
  • Salunkhe, A.B., et al., 2016. Water dispersible superparamagnetic Cobalt iron oxide nanoparticles for magnetic fluid hyperthermia. Journal of magnetism and magnetic materials, 419, 533–542.
  • Satapathy, B.S., et al., 2016. Lipid nanocarrier-based transport of docetaxel across the blood brain barrier. RSC advances, 6 (88), 85261–85274.
  • Shaw, T.K., et al., 2017. Successful delivery of docetaxel to rat brain using experimentally developed nanoliposome: a treatment strategy for brain tumor. Drug delivery, 24 (1), 346–357.
  • Shirshahi, V., et al., 2013. Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticles. Cancer nanotechnology, 4 (1–3), 27–37.
  • Tietze, R., et al., 2015. Magnetic nanoparticle-based drug delivery for cancer therapy. Biochemical and biophysical research communications, 468 (3), 463–470.
  • Wabler, M., et al., 2014. Magnetic resonance imaging contrast of iron oxide nanoparticles developed for hyperthermia is dominated by iron content. International journal of hyperthermia: the official journal of European society for hyperthermic oncology, North American hyperthermia group, 30 (3), 192–200.
  • Wang, L., Yang, C., and Wang, J., 2012. Effects of loading procedures of magnetic nanoparticles on the structure and physicochemical properties of cisplatin magnetic liposomes. Journal of microencapsulation, 29 (8), 781–789.
  • Wang, G., et al., 2018. Controlled synthesis of L-cysteine coated cobalt ferrite nanoparticles for drug delivery. Ceramics international, 44 (12), 13588–13594.
  • Wu, X., et al., 2016. PEG-assisted hydrothermal synthesis of CoFe2O4 nanoparticles with enhanced selective adsorption properties for different dyes. Applied surface science, 389, 1003–1011.
  • Zamani, M., et al., 2019. Co1 − XZnxFe2O4 based nanocarriers for dual-targeted anticancer drug delivery: synthesis, characterization and in vivo and in vitro biocompatibility study. Journal of molecular liquids, 274, 60–67.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.